Ischemic bowel disease in 2021  

作　　者：Monjur Ahmed 

机构地区：[1]Department of Medicine,Division of Gastroenterology and Hepatology,Thomas Jefferson University,Philadelphia,PA 19107,United States

出　　处：《World Journal of Gastroenterology》2021年第29期4746-4762,共17页世界胃肠病学杂志（英文版）

摘　　要：Ischemic bowel disease(ISBODI)includes colon ischemia,acute mesenteric ischemia(AMI)and chronic mesenteric ischemia(CMI).Epidemiologically,colon ischemia is the most common type followed by AMI and CMI.There are various risk factors for the development of ISBODI.Abdominal pain is the common presenting symptom of each type.High clinical suspicion is essential in ordering appropriate tests.Imaging studies and colonoscopy with biopsy are the main diagnostic tests.Treatment varies from conservative measures to surgical resection and revascularization.Involvement of multidisciplinary team is essential in managing ISBODI.Although open surgery with revascularization plays an important role,recently there is an increasing interest in percutaneous endovascular treatment.

关 键 词：Colon ischemia Ischemic colitis Acute mesenteric ischemia Chronic mesenteric ischemia Endovascular treatment of acute and chronic mesenteric ischemia 

分 类 号：R574[医药卫生—消化系统]